Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group
Files
Publication date
2019-06
Authors
Kwakman, Johannes J M
van Werkhoven, Erik
Simkens, Lieke H J
van Rooijen, Johan M
van de Wouw, Yes A J
Tije, Albert J Ten
Creemers, Geert-Jan M
Hendriks, Mathijs P
Los, Maartje
van Alphen, Robbert J
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Gastroenterology, Oncology, Letter
Citation
Kwakman, J J M, van Werkhoven, E, Simkens, L H J, van Rooijen, J M, van de Wouw, Y A J, Tije, A J T, Creemers, G-J M, Hendriks, M P, Los, M, van Alphen, R J, Polée, M B, Muller, E W, van der Velden, A M T, van Voorthuizen, T, Koopman, M, Mol, L & Punt, C J A 2019, 'Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group', Clinical colorectal cancer, vol. 18, no. 2, pp. e229-e230. https://doi.org/10.1016/j.clcc.2019.01.002